What moved IHL.AX stock on 13 Jan 2026?

IHL.AX fell to A$0.041 on 13 Jan 2026 on heavy volume of 61,360,016 shares. The move reflected speculative trading and profit taking ahead of clinical milestones and earnings updates.

What is Meyka AI's rating and outlook for IHL.AX?

Meyka AI rates IHL.AX **61.15 (B)** with a HOLD suggestion. The model projects A$0.070 in 12 months, but this is a model projection and not a guarantee.

What are the main risks for IHL.AX investors?

Key risks include negative earnings (EPS -1.30), high R&D spending, binary clinical outcomes and a small market cap. These factors can cause sharp price swings and liquidity shifts.

Where can I follow IHL.AX news and updates?

Monitor company releases, ASX filings, and market coverage. See the Meyka IHL.AX stock page for live data and recent references such as Investing.com for ADR coverage [source](https://sa.investing.com/equities/incannex-healthcare-adr).

AU Stocks

IHL.AX Incannex Healthcare (ASX) falls to A$0.041 on 13 Jan 2026: heavy volume signals trader focus

ByDanny Kontos January 13, 2026January 13, 2026

Market closed: IHL.AX stock finished the session at A$0.041 on 13 Jan 2026 after a -10.87% move on exceptionally high turnover. Trading volume reached 61,360,016 shares versus an average of 6,427,691, giving a relative volume of 9.55 and making IHL.AX one of the most active names on the ASX today. The drop pushed the share price to its day low A$0.041 and sits well below the 50‑day average of A$0.065 and the 200‑day average of A$0.103, underlining short‑term selling pressure and elevated trader interest.